Professional Documents
Culture Documents
Control de Lectura 1
Control de Lectura 1
Control de Lectura 1
Enlace:https://www.theguardian.com/world/2020/may/27/americans-covid-19-vaccine-
poll
NOTICIA:
Ilustración 1. The first patient enrolled in Pfizer’s Covid-19 vaccine clinical trial at the University of Maryland School
of Medicine in Baltimore, receives an injection, on 4 May
Only about half of Americans say they would get a Covid-19 vaccine if
available, according to an Associated Press-NORC poll, as a top US
government scientist tempered claims by Donald Trump that the United States
would be able to invent, manufacture and administer hundreds of millions of
vaccine doses by the end of the year.
In previous years, Trump has added his voice to the anti-vaccination movement
in the United States, falsely linking vaccines with autism. The movement has
contributed to outbreaks of measles in the United States and raised fears about
the potential return of eradicated diseases such as smallpox.
Early clinical trials from multiple vaccine candidates have been promising. But
Dr Anthony Fauci, the country’s top infectious diseases expert and a member of
the White House coronavirus taskforce, warned in an interview with CNN on
Wednesday that the road to a vaccine could have unforeseen detours.
Asked whether a vaccine would be widely available in the United States “before
the end of the year,” Fauci said “it is possible.
“But when you’re dealing with vaccines, you’ve got to remember that you’re
dealing with things that have a lot of vicissitudes,” Fauci said. “There are a lot of
landmines and hiccups that occur.
Fauci said that scientists were accelerating the vaccine development process
“which I must emphasize is not at the expense of safety nor at the expense of
scientific integrity.
“I still think that we have a good chance, if all the things fall in the right place,
that we might have a vaccine that would be deployable by the end of the year,
by November-December,” he said.
Respondents in the poll told the Associated Press said they were concerned
about the vaccine development process being rushed. The record time for
developing an entirely new vaccine is at least four years.
Dr Francis Collins, who directs the National Institutes of Health, insisted safety
was the top priority. The NIH is creating a master plan for testing the leading
Covid-19 vaccine candidates in tens of thousands of people, to prove if they
really work and also if they’re safe.
“I would not want people to think that we’re cutting corners because that would
be a big mistake. I think this is an effort to try to achieve efficiencies, but not to
sacrifice rigor,” Collins told the AP earlier this month.
Resumen y opinión:
Yo opino que ante nuevos productos en este caso vacunas para combatir el
nuevo virus, las personas tendrán incertidumbre sobre la seguridad del
producto, y es un porcentaje significativo, para este caso en una muestra la
mitad tenía recelo de vacunarse. Este miedo debería quitarse ya que los
encargados de realizarlas cuentan con la tecnología necesaria para hacerlo,
además de estar respaldadas por estudios y numerosas pruebas realizadas,
por lo que el producto final no debería ser perjudicial, sino todo lo contrario.